Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhys Jones

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of CancerKevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease riskTobi Alegbe, Bradley T Harris, Laura Fachal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
Nature|June 3, 2026
Cell-type-resolved genetic variation shapes inflammatory bowel disease riskTobi Alegbe, Bradley T Harris, Laura Fachal, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Gut|April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemicNicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Nature Genetics|June 15, 2026
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesisMonika Krzak, Tobi Alegbe, D Leland Taylor, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of CancerKevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease riskTobi Alegbe, Bradley T Harris, Laura Fachal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2024
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
Nature|June 3, 2026
Cell-type-resolved genetic variation shapes inflammatory bowel disease riskTobi Alegbe, Bradley T Harris, Laura Fachal, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Nature Reviews. Neurology|June 12, 2024
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's DiseaseSuzanne E Schindler, Douglas Galasko, Ana C Pereira, et al.
Gut|April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemicNicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
Nature Genetics|June 15, 2026
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesisMonika Krzak, Tobi Alegbe, D Leland Taylor, et al.
Pageof 21